D. E. Shaw & Co., Inc. Avita Medical, Inc. Transaction History

D. E. Shaw & Co., Inc.

$98.6 Billion
Q2 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Avita Medical, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 84,829 shares of RCEL stock, worth $911,063. This represents 0.0% of its overall portfolio holdings.

Number of Shares

84,829

Previous 48,129 76.25%

Holding current value

$911,063

Previous $771,000 12.97%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$7.92 - $15.55 $290,664 - $570,685	36,700 Added 76.25%	84,829 $671,000
Q1 2024 May 15, 2024	SELL	$12.56 - $18.31 $30,483 - $44,438	-2,427 Reduced 4.8%	48,129 $771,000
Q4 2023 Feb 14, 2024	SELL	$9.29 - $14.57 $28,427 - $44,584	-3,060 Reduced 5.71%	50,556 $693,000
Q3 2023 Nov 14, 2023	SELL	$13.84 - $20.79 $356,227 - $535,113	-25,739 Reduced 32.44%	53,616 $783,000
Q2 2023 Aug 14, 2023	SELL	$10.7 - $17.48 $442,380 - $722,693	-41,344 Reduced 34.25%	79,355 $1.35 Million
Q1 2023 May 15, 2023	BUY	$6.45 - $14.48 $586,866 - $1.32 Million	90,987 Added 306.23%	120,699 $1.69 Million
Q4 2022 Feb 14, 2023	BUY	$4.53 - $7.55 $44,715 - $74,526	9,871 Added 49.75%	29,712 $196,000
Q3 2022 Nov 14, 2022	SELL	$4.97 - $7.89 $1,575 - $2,501	-317 Reduced 1.57%	19,841 $105,000
Q2 2022 Aug 15, 2022	SELL	$4.6 - $8.82 $45,802 - $87,820	-9,957 Reduced 33.06%	20,158 $96,000
Q1 2022 May 16, 2022	BUY	$6.96 - $12.15 $209,600 - $365,897	30,115 New	30,115 $255,000
Q4 2021 Feb 14, 2022	SELL	$11.72 - $19.66 $151,961 - $254,911	-12,966 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$16.73 - $20.9 $49,671 - $62,052	2,969 Added 29.7%	12,966 $230,000
Q2 2021 Aug 16, 2021	BUY	$17.23 - $22.02 $172,248 - $220,133	9,997 New	9,997 $205,000

Others Institutions Holding RCEL

# of Institutions

Shares Held

6.03M

Call Options Held

11.6K

Put Options Held

40.1K

View Full List

About AVITA Medical, Inc.

Ticker RCEL
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 25,030,900
Market Cap $269M
Description
AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and prop...

More about RCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account